SMTL ID : 6t9s.1

Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1S)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

2 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUC.1: 1 residues within 4Å: Chain A: N.57 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.57 NAG-FUC.2: 5 residues within 4Å: Chain A: N.241, N.245, L.249, F.278, P.281 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:L.249 Hydrogen bonds: A:F.278, A:N.245

1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(5-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.3: 4 residues within 4Å: Chain A: G.336, S.338, N.341, N.342 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:G.336

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.4: 5 residues within 4Å: Chain A: T.234, R.242, L.286, S.287, V.288 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:W.231, A:R.242, A:R.242, A:L.286, A:V.288

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.5: 2 residues within 4Å: Chain A: N.106, N.188 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.188 NAG.6: 3 residues within 4Å: Chain A: N.256, T.258, E.259 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.256, A:T.258 NAG.7: 2 residues within 4Å: Chain A: R.465, N.485 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.485

1 x MXK: (2~{E})-2-hydroxyimino-~{N}-[(1~{S})-3-[4-[(2-methylimidazol-1-yl)methyl]-1,2,3-triazol-1-yl]-1-phenyl-propyl]ethanamid e(Non-covalent)

MXK.8: 14 residues within 4Å: Chain A: N.68, I.69, D.70, W.82, G.115, G.116, G.117, T.120, E.197, P.285, L.286, F.329, H.438, G.439 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:N.68, A:D.70 Water bridges: A:G.116, A:G.117 pi-Stacking: A:W.82

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.9: 3 residues within 4Å: Chain A: S.487, T.488, T.508 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:R.470, A:T.488, A:T.488, A:T.508, A:T.508 SO4.10: 4 residues within 4Å: Chain A: Q.316, G.413, N.414, N.415 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:Q.316, A:G.413, A:N.414, A:N.415

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Marakovic, N. et al., Enantioseparation, in vitro testing, and structural characterization of triple-binding reactivators of organophosphate-inhibited cholinesterases. Biochem.J. (2020)

Release Date

2020-07-15

Peptides

Cholinesterase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cholinesterase

Related Entries With Identical Sequence